Healthcare

Clean capital: Record fundraising for impact funds creates pools of do-good money
-
Louise Weihart
Analytics Reporter, ION Analytics
Following the science: dealmakers step up chase for CROs in Australia, New Zealand
-
EC review of Novozymes and Chr. Hansen tie-up likely time-consuming, with verticals and innovation in the mix
-
German health minister’s ‘locust’ sponsor comments spook live healthcare deals – market sources
- New investors scared by minister’s remarks on limiting outpatient profit
- Rush to consolidate and buy ‘plan hospitals’ before any new laws
- Small clinics with succession problems hurry to exit
-
South Korea’s ramped up FDI regulation hinders Chinese semiconductor and biotechnology M&A attempts
- NASIA strengthens existing FDI regulation of ‘national core technologies’
- Chinese investments in sensitive sectors face deep scrutiny, longer reviews
- Cowin DST suitor Focuslight expects to hear from MOTIE in February
- Ramped up FDI screening comes after government found over 100 tech leakages
-
- Innovation, price and complaints key factors for Art 22
- Horizon/Amgen bullish on regulatory clearances
- Biologics portfolios cover similar therapeutic areas with no obvious overlaps
-
No more items to load
Load moreSomething went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports